Does TAFASITAMAB Cause Breakthrough covid-19? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Breakthrough covid-19 have been filed in association with TAFASITAMAB (MONJUVI). This represents 0.4% of all adverse event reports for TAFASITAMAB.
6
Reports of Breakthrough covid-19 with TAFASITAMAB
0.4%
of all TAFASITAMAB reports
0
Deaths
6
Hospitalizations
How Dangerous Is Breakthrough covid-19 From TAFASITAMAB?
Of the 6 reports, 6 (100.0%) required hospitalization, and 2 (33.3%) were considered life-threatening.
Is Breakthrough covid-19 Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAFASITAMAB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does TAFASITAMAB Cause?
Disease progression (470)
Diffuse large b-cell lymphoma (346)
Off label use (203)
Death (146)
Neutropenia (99)
Covid-19 (96)
General physical health deterioration (75)
Pneumonia (66)
Febrile neutropenia (64)
Drug ineffective (62)
What Other Drugs Cause Breakthrough covid-19?
RITUXIMAB (84)
CILGAVIMAB\TIXAGEVIMAB (51)
PREDNISONE (44)
CYCLOPHOSPHAMIDE (30)
VINCRISTINE (29)
DOXORUBICIN (26)
METHOTREXATE (26)
BENDAMUSTINE (23)
TOZINAMERAN (19)
ELASOMERAN (18)
Which TAFASITAMAB Alternatives Have Lower Breakthrough covid-19 Risk?
TAFASITAMAB vs TAFASITAMAB-CXIX
TAFASITAMAB vs TAFINLAR
TAFASITAMAB vs TAFLUPROST
TAFASITAMAB vs TAGRAXOFUSP-ERZS
TAFASITAMAB vs TAHOR